The goal of my research program is to work with knowledge users to inform national and international decisions about optimal infectious disease control and prevention strategies, and to provide better modeling tools for policy decisions. My team and I develop state-of-the-art transmission-dynamic models, analyze large population-level datasets, and use epidemiology and health economics to estimate the effectiveness and cost-effectiveness of infectious disease control and prevention strategies at the population-level and within vulnerable or at-risk groups.
Marc Brisson presented to the Canadian National Advisory Committee on Immunization (NACI) HPV workgroup meeting on February 8, 2024: “Potential impact of switching from a 2-dose to 1-dose routine HPV vaccination program in Canada”.
Marc Brisson was invited speaker at the MIDSEA online seminar series on January 17, 2024. He presented ‘Modeling the population-level impact of HPV vaccination to help inform policy decisions’ [ MIDSEA ]
‘Association of naturally acquired type-specific HPV antibodies and subsequent HPV re-detection: systematic review and meta-analysis’ [ Infect Agents Cancer ]
Marc Brisson was interviewed by Courrier Laval: ‘Prévenir les cancers du col de l’utérus une dose à la fois’ (Preventing cervical cancers one dose at a time), following our article in The Lancet Public Health.